Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2015 1
2016 1
2017 1
2018 1
2019 3
2020 13
2021 11
2022 12
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
A Multinational Case Series Describing Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection Caused by Omicron Sublineages With Prolonged Courses of Nirmatrelvir/Ritonavir.
Snell LB, McGreal-Bellone A, Nye C, Gage S, Bakrania P, Williams TGS, Aarons E, Botgros A, Douthwaite ST, Mallon P, Milligan I, Moore C, O'Kelly B, Underwood J, de Barra E, Nebbia G. Snell LB, et al. Among authors: de barra e. Open Forum Infect Dis. 2023 Dec 7;11(1):ofad612. doi: 10.1093/ofid/ofad612. eCollection 2024 Jan. Open Forum Infect Dis. 2023. PMID: 38269048 Free PMC article.
Development of a novel medium throughput flow-cytometry based micro-neutralisation test for SARS-CoV-2 with applications in clinical vaccine trials and antibody screening.
O'Reilly S, Kenny G, Alrawahneh T, Francois N, Gu L, Angeliadis M, de Masson d'Autume V, Garcia Leon A, Feeney ER, Yousif O, Cotter A, de Barra E, Horgan M, Mallon PWG, Gautier V. O'Reilly S, et al. Among authors: de barra e. PLoS One. 2023 Nov 30;18(11):e0294262. doi: 10.1371/journal.pone.0294262. eCollection 2023. PLoS One. 2023. PMID: 38033116 Free PMC article.
Impact of vaccination and variants of concern on long COVID clinical phenotypes.
Kenny G, McCann K, O'Brien C, O'Broin C, Tinago W, Yousif O, O'Gorman T, Cotter AG, Lambert JS, Feeney ER, de Barra E, Sadlier C, Landay A, Doran P, Savinelli S, Mallon PWG; All Ireland Infectious Diseases Cohort Study. Kenny G, et al. Among authors: de barra e. BMC Infect Dis. 2023 Nov 16;23(1):804. doi: 10.1186/s12879-023-08783-y. BMC Infect Dis. 2023. PMID: 37974068 Free PMC article.
Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severity.
MacCann R, Ghosh TS, Garcia Leon AA, Li J, Negi R, Gaillard C, Saini G, Tinago W, Feeney ER, Yousif O, Cotter AG, de Barra E, Sadlier C, Doran P, Landay A, O'Toole PW, Mallon PW; All Ireland Infectious Diseases cohort study. MacCann R, et al. Among authors: de barra e. Microbes Infect. 2024 Mar-Apr;26(3):105247. doi: 10.1016/j.micinf.2023.105247. Epub 2023 Nov 8. Microbes Infect. 2024. PMID: 37944587 Free article.
Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time.
Kenny G, O'Reilly S, Wrigley Kelly N, Negi R, Gaillard C, Alalwan D, Saini G, Alrawahneh T, Francois N, Angeliadis M, Garcia Leon AA, Tinago W, Feeney ER, Cotter AG, de Barra E, Yousif O, Horgan M, Doran P, Stemler J, Koehler P, Cox RJ, O'Shea D, Olesen OF, Landay A, Hogan AE, Lelievre JD, Gautier V, Cornely OA, Mallon PWG; All Ireland Infectious Diseases Cohort Study; VACCELERATE Consortium EU-COVAT-1-AGED Part A Study Group. Kenny G, et al. Among authors: de barra e. Nat Commun. 2023 Nov 2;14(1):7015. doi: 10.1038/s41467-023-42717-1. Nat Commun. 2023. PMID: 37919289 Free PMC article.
UK consensus definitions for necrotising otitis externa: a Delphi study.
Hodgson SH, Khan MM, Patrick-Smith M, Martinez-Devesa P, Stapleton E, Williams OM, Pretorius P, McNally M, Andersson MI; UK NOE Collaborative. Hodgson SH, et al. BMJ Open. 2023 Feb 20;13(2):e061349. doi: 10.1136/bmjopen-2022-061349. BMJ Open. 2023. PMID: 36806133 Free PMC article. Review.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D; EU SolidAct study group. Trøseid M, et al. Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8. Crit Care. 2023. PMID: 36627655 Free PMC article. Clinical Trial.
44 results